DYSF and hyperinsulinemic hypoglycemia, familial, 4: We further show that blocking IL-1β leads to a marked improvement of muscle differentiation in vitro, suggesting that blockade of IL-1β in vivo may be a therapeutic target for dysferlin deficiency.